Susquehanna Fundamental Investments’s Zymeworks ZYME Stock Holding History

Susquehanna Fundamental Investments’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-17,090	Closed	-$204K	–	1046
2025 Q1	$204K	Sell	17,090 -80,463	-82%	-$1.1M	﹤0.01%	999
2024 Q4	$1.43M	Buy	+97,553	New	+$1.36M	0.02%	618
2024 Q2	$507K	Buy	59,523 +4,444	+8%	+$39.6K	0.01%	689
2024 Q1	$579K	Buy	+55,079	New	+$612K	0.03%	445
2023 Q3	–	Sell	-31,930	Closed	-$276K	–	607
2023 Q2	$276K	Hold	31,930	–	–	0.01%	533
2023 Q1	$289K	Hold	31,930	–	–	0.01%	796
2022 Q4	$251K	Buy	+31,930	New	+$224K	﹤0.01%	1026
2021 Q1	–	Sell	-31,292	Closed	-$1.48M	–	1633
2020 Q4	$1.48M	Buy	31,292 +26,184	+513%	+$1.22M	0.03%	722
2020 Q3	$238K	Buy	+5,108	New	+$175K	0.01%	1137

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Susquehanna Fundamental Investments's ZYME Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Zymeworks (ZYME) in Q2 2025, closing a stake of 17,090 shares — an estimated $204K sold.

Susquehanna Fundamental Investments first reported a position in ZYME in Q3 2020 and held it in 9 quarters. The position peaked at $1.48M in Q4 2020. 181 funds tracked by Wall St. Rank hold ZYME as of Q2 2025.

Susquehanna Fundamental Investments reported no remaining Zymeworks position as of Q2 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 17,090 Zymeworks shares in Q2 2025, an estimated $204K.
Susquehanna Fundamental Investments first reported a position in Zymeworks in Q3 2020 and held it in 9 quarters.
Susquehanna Fundamental Investments's Zymeworks position peaked at $1.48M in Q4 2020.
181 funds tracked by Wall St. Rank held Zymeworks as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.